Mutation and Abnormal Expression of the Fragile Histidine Triad Gene in Nasopharyngeal Carcinoma

This publication has 12 references indexed in Scilit:

• Role of FHIT in Human Cancer
  Journal of Clinical Oncology, 1999
• Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck
  Oncogene, 1998
• AnFHIT tumor suppressor gene?
  Genes, Chromosomes and Cancer, 1998
• Sequence of the FRA3B common fragile region: Implications for the mechanism of FHIT deletion
  Proceedings of the National Academy of Sciences, 1997
• Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection
  British Journal of Cancer, 1997
• Precise localization of theFHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affectFHIT transcription in tumor cell lines
  Genes, Chromosomes and Cancer, 1997
• FHIT gene alterations in head and neck squamous cell carcinomas.
  Proceedings of the National Academy of Sciences, 1996
• The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers
  Cell, 1996
• FRA3B Extends Over a Broad Region and Contains a Spontaneous HPV16 Integration Site: Direct Evidence for the Coincidence of Viral Integration Sites and Fragile Sites
  Human Molecular Genetics, 1996
• Fhit, a Putative Tumor Suppressor in Humans, Is a Dinucleoside 5‘,5‘ ‘‘-P¹,P³-Triphosphate Hydrolase
  Biochemistry, 1996